Ultima Genomics

High-throughput genomic sequencing services

Newark, New Jersey, United States

About Ultima Genomics

Ultima Genomics focuses on improving human health through advanced genomic sequencing technologies. The company processes large amounts of genetic data to provide insights into human biology and diseases. Its clients include academic researchers, pharmaceutical companies, and healthcare providers who need accurate genomic data for their work. The key feature of Ultima Genomics is its sequencing architecture, which allows for extensive data collection from samples, detection of small genetic variations, and routine testing for early disease detection. This capability gives clients access to high-quality genomic information that is essential for research and clinical applications. Ultima Genomics stands out from competitors by excelling in breadth, depth, and frequency of data collection, enabling significant advancements in genomics. The company's goal is to continuously innovate and expand its services to help clients achieve breakthroughs in understanding and treating diseases.

Newark, New JerseyHeadquarters
2016Year Founded
$587.7MTotal Funding
LATE_VCCompany Stage
Biotechnology, HealthcareIndustries
201-500Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
401(k) Retirement Plan
Paid Holidays
Paid Vacation
Employee Assistance Program

Risks

Competition from Illumina and BGI threatens Ultima's market share in low-cost sequencing.
Rapid technological advancements may render Ultima's current technologies obsolete.
Ethical and privacy concerns could lead to regulatory challenges for Ultima Genomics.

Differentiation

Ultima Genomics offers a revolutionary sequencing architecture with the UG 100 platform.
The UG 100 system enables cost-effective sequencing, targeting the $100 genome milestone.
Ultima's technology provides ultra-high accuracy for detecting single nucleotide variants.

Upsides

Ultima's UG 100 platform was selected for the UK's largest proteomics study.
Collaborations with Labcorp and Hartwig Medical enhance Ultima's clinical applications.
The UG 100 system's low cost and high accuracy drive adoption in precision oncology.